Plus [ftcn]    
therapy [ftcn]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
CHRONIC HEPATITIS [dsyn]    
Objective [inpr]    
Study [mnob]    
Long-Term Effects [phpr]    
Plus [ftcn]    
Combination Therapy [topp]    
Clarify [acty]    
therapy [ftcn]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
Chronic hepatitis C [dsyn]    
Patients [podg]    
Infected [fndg]    
HEPATITIS C VIRUS [virs]    
Trial, Multicentre [resa]    
Patients [podg]    
Treated [ftcn]    
Combination [qlco]    
IFN Alpha therapy [topp]    
2b [inpr]    
Plus [ftcn]    
Examined [fndg]    
HEPATOCELLULAR CARCINOMA [neop]    
Combination Therapy [topp]    
Risk Factors [qnco]    
Liver Carcinogenesis [neop]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Patients [podg]    
Cumulative [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
LOWER [spco]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Patients [podg]    
{Non-patient} [clna]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Cumulative [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Transient Group [popg]    
Response [orga]    
Response [orga]    
NR [geoa]    
Group [idcn]    
Regression Analysis [inpr]    
Indicated [fndg]    
Following [tmco]    
Risk Factors [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
YEARS [tmco]    
Advanced [qlco]    
Histological [ftcn]    
Staging [ftcn]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
therapy [ftcn]    
Cumulative [qlco]    
Incidence Rate [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
LOWER [spco]    
Patients [podg]    
Average [qnco]    
ALT [neop]    
Levels [qlco]    
IU/L [qnco]    
Average [qnco]    
serum ALT [lbpr]    
Levels [qlco]    
IU/L [qnco]    
Combination Therapy [topp]    
Suggest [idcn]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
CONTINUOUS [idcn]    
Normalization [resa]    
ALT [neop]    
Levels [qlco]    
therapy [ftcn]    
Affect [menp]    
Patients [podg]    
HEPATOCELLULAR CARCINOMA [neop]    
